+91-8668442535

Allergy Diagnostics And Treatment Market By Product Type (Assay Kits, Consumables, Services), By Test Type (In Vivo Tests, In Vitro Tests), By Treatment Type (Antihistamines, Autoinjectable Epinephrine, Corticosteroids, Decongestants, Immuno Modulators, Immunotherapy, Leukotriene Inhibitors, Mast Cell Stabilizers, Nasal Anticholinergics), By Allergen Type (Food Allergen, Inhaled Allergen, Drug Allergen, Other Allergen) - Growth, Future Prospects, And Competitive Analysis, 2017 -2025

Allergy is the immune reaction to a foreign body called an allergen; it may arise due to food consumed, inhaled into the lungs, or in contact with the skin through an injectable agent or touch. Allergic diseases rank fifth among the leading chronic diseases across all age groups in the U.S. Over the course of 50 years of global industrialization; there has been a substantial rise in the prevalence of allergic diseases. According to the World Allergy Organization (WAO) study, the prevalence of allergy ranges from 10% to 40% across all age groups of the population. The allergic disease affects more than one billion people worldwide and is anticipated to reach four billion in 2050. This increases both the direct and indirect burden in terms of rising healthcare costs, decreased productivity, and a negative impact on quality of life. Thus, the rising prevalence of allergic diseases, as well as the introduction of novel diagnostic and treatment products, are driving the growth of the allergy diagnostics and treatment market.

The report titled "Allergy Diagnostics and Treatment Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025" offers strategic insights into the overall allergy diagnostics and treatment market, along with the market size and estimates for the duration of 2015–2025. The said research study covers an in-depth analysis of multiple market segments based on types of diagnostic products, allergens, tests, treatments, and different geographies. The diagnostic product types studied for analyzing the overall global allergy diagnostics and treatment market are majorly segmented into instruments, consumables, services, and other products. By allergen type, the allergy diagnostics and treatment market is segmented into food, inhaled, drug, and other allergens. On the basis of test types, they are further segmented as in vivo and in vitro tests. According to treatment type, the market is segmented into antihistamines, auto-injectable epinephrine, corticosteroids, decongestants, immunomodulators, immunotherapy, leukotriene inhibitors, mast cell stabilizers, and nasal anticholinergics.

 

The market size and forecast for these regional and country-level markets are presented in this study for the period 2015–2025. Market growth rates for the forecast period 2017–2025 are also included in this report, considering 2016 as the base year. This section also includes additional cross-sectional analysis of diagnostic products, allergens, tests, treatments, and constituent country-level markets.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global allergy diagnostics and treatment market. Tools such as key player market positioning and an appealing investment proposition provide readers with insights into the global allergy diagnostics and treatment market's competitive scenario. This report concludes with a company profiles section that highlights major information about the key players engaged in the global allergy diagnostics and treatment market. In-depth competitive environment analysis and historical (2015) market size data are also provided in the report.

Furthermore, this report concludes with a profile of key market players currently enjoying prominent positions in the allergy diagnostics and treatment market. The key players profiled in this report are Alcon Laboratories, Inc., bioMerieux, Danaher Corporation, Hitachi Chemical Diagnostics, HOB Biotech Group, Hycor Biomedical, Lincoln Diagnostics, Omega Diagnostics, Siemens Healthcare, Stallergenes Greer, Thermo Fisher Scientific, and others.

Based on the type of products, the global allergy diagnostics market is segmented as follows:

  • Assay Kits
  • Consumables
  • Instruments

Among the product types, consumables dominate the global allergy diagnostics and treatment market, and it is also the fastest-growing market, followed by assay kits and instruments. Consumables are required on a large scale, so high volume and low cost play an important role in occupying a greater share of the global allergy diagnostics and treatment market. The current assays are simple to use and handle, with high-precision results. These diagnostic kits are more time-saving and show enhanced sensitivity.

Based on the type of tests, the global allergy diagnostics market is segmented as follows:

  • In vivo tests
  • In vitro tests

In 2016, in vivo tests dominated the global allergy diagnostics market. In vivo testing is faster, more sensitive, and less expensive than in vitro testing, so it is preferred. Currently, skin tests are the best available option for the detection of allergen-specific IgE. The adoption of skin tests among healthcare professionals and patients is high. In vitro tests are carried out in certain circumstances, such as if the skin is abnormal or a history of sensitivity is observed in the patient. While rising demand for less invasive diagnostics drives laboratory technological advancement, the in vitro testing segment is expanding.

Based on the type of treatment, the global allergy treatment market is segmented as follows:

  • Antihistamines
  • Autoinjectable Epinephrine
  • Corticosteroids
  • Decongestants
  • Immunomodulators
  • Immunotherapy
  • Leukotriene Inhibitors
  • Mast Cell Stabilizers
  • Nasal Anticholinergics

In 2016, antihistamines were the most commonly used treatment for allergic diseases, thus dominating the global allergy treatment market. Corticosteroids, which are highly effective allergy medications, are the next to hit the market. Immunotherapy is expected to be the fastest-growing segment in the allergy treatment market. Immunotherapy is showing fast adoption as it is cost-effective, decreases sensitivity to allergens, and provides long-lasting relief from allergy symptoms.

Based on the type of allergen, the global allergy diagnostics and treatment market is segmented as follows:

  • Food Allergens
  • Inhaled Allergens
  • Drug Allergens
  • Other

The rising incidence of inhaled allergies and asthma due to growing pollution and urbanization contributes to the growth of the allergy diagnostics and treatment market. Thus, inhaled allergens occupy the largest revenue share for the year 2016. Allergic rhinitis affects almost 10%–30% of the adult population and 40% of children. Global warming and changes in pollination seasons are some of the major reasons for the growing incidence of asthma and allergic rhinitis. Food allergies are more commonly observed in children than in adults. Drug allergens are anticipated to be the fastest-growing segment during the forecast period of 2017–2025.

For the purpose of this study, the global allergy diagnostic and treatment market is geographically categorized into:

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • rest of Latin America
  • Middle East and Africa
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of the Middle East and Africa

At present, North America occupies the largest share of the global allergy diagnostic and treatment market, followed by Europe. The rising incidence of allergic diseases, particularly those related to respiratory function, increasing awareness of allergy diagnostics, a well-supported healthcare structure, favorable reimbursement policies, and enhanced diagnostic technology are some of the major driving factors for the allergy diagnostics and treatment market. Around 150 million Europeans suffer from chronic allergic diseases, which are predicted to cover almost half the population of Europe by 2025. One of the key factors driving the allergy diagnostics and treatment market is an increase in the geriatric population. Asia Pacific is anticipated to be the fastest-growing allergy diagnostics and treatment market in the forecast period. The rising prevalence of allergic diseases and asthma, particularly in developing countries, poses a major threat to health and economies. Thus, high unmet needs, improved healthcare infrastructure, rising pollution, and increasing disposable income are some of the factors governing the demand for allergy diagnostics and treatment in the Asia Pacific region.

Frequently Asked Questions:

The market for Allergy Diagnostics And Treatment is expected to reach US$ 45,018 Mn in 2025.

The Allergy Diagnostics And Treatment market is expected to see significant CAGR growth over the coming years, at 5.6%.

The report is forecasted from 2015-2025.

The base year of this report is 2014.

Alcon Laboratories Inc.,BioMerieux Inc.,Danaher Corporation,Hitachi Chemical Diagnostics, Inc,HOB Biotech Group Co.,Ltd. are some of the major players in the global market.

Choose License Type
Trusted By
Godaddy
Published Date:  Jul 2017
Category:  Pharmaceuticals
Report ID:   58566
Report Format:   PDF
Pages:   120
Rating:    4.7 (70)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support